DV vs REGN · P/E 31, rev $656.8M vs P/E 14, rev $14.34B
DoubleVerify Holdings Inc (DV) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
DoubleVerify Holdings Inc (DV) is a advertising agencies company listed on NYSE.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported DV revenue for 2024-12-31 was $656.8M. Net income was $56.2M. Revenue was up 14.7% from 2023-12-31 to 2024-12-31. DV currently screens at market cap $1.57B and trailing P/E 30.9.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
DV currently screens at market cap $1.57B and trailing P/E 30.9. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the DV and REGN stock pages for the full models.
Not investment advice.